Fushimi Atsushi, Fukushima Naoko, Suzuki Toshimasa, Kudo Rei, Takeyama Hiroshi
Department of Surgery, Sakuragaoka Hospital, Shizuoka, Japan.
Department of Surgery, The Jikei University School of Medicine, Tokyo, Japan.Email:
Asian Pac J Cancer Prev. 2018 Dec 25;19(12):3591-3596. doi: 10.31557/APJCP.2018.19.12.3591.
Background: There is no decrease in the number of breast cancer deaths if screening mammography is performed in women aged <40 years. However, NCCN guidelines recommend screening mammography in young women at risk of hereditary breast cancer. Therefore, more accurate screening mammography for young women is needed. Objective: To evaluate the features of screening mammographic findings, particularly microcalcifications, in women aged <50 years to increase the positive predictive value of screening mammography in young women. Methods: We retrospectively reviewed the data of consecutive women who underwent opportunistic and organized breast cancer screening at the Sakuragaoka Hospital (Shizuoka, Japan) between April 2013 and March 2015. We compared the mammographic findings and features of microcalcifications between women aged <40 and 40–49 years and those aged 50–74 years. Results: The study included 3645 women. Of these 3645 women, 415 (11.4%) were aged <40 years, 1219 (33.4%) were aged 40–49 years, and 2011 (55.2%) were aged 50–74 years. Women aged <50 years were more likely to be recalled for microcalcifications than those aged 50–74 years (<40 years, 4.8%; 40–49 years, 4.3%; 50–74 years, 3.3%). Young women were more likely to be recalled for small round and segmental microcalcifications [<40 years, odds ratio (OR): 1.799 (95% CI: 0.751–2.846); 40–49 years, OR: 1.394 (95% CI: 0.714–2.074)] and less likely to be recalled for small round and grouped microcalcifications [<40 years, OR: 0.603 (95% CI: 0.181–1.025); 40–49 years, OR: 0.961 (95% CI: 0.496–1.428)] compared with women aged 50–74 years. Conclusions: On screening mammography, women aged <50 years had a higher tendency to be recalled for microcalcifications, particularly small round and segmental microcalcifications. False-positive results may be reduced by reflecting the characteristics of microcalcification findings among young women without breast cancer in the future.
对于年龄小于40岁的女性进行乳腺钼靶筛查,乳腺癌死亡人数并未减少。然而,美国国立综合癌症网络(NCCN)指南建议对有遗传性乳腺癌风险的年轻女性进行乳腺钼靶筛查。因此,需要针对年轻女性开发更准确的乳腺钼靶筛查方法。目的:评估年龄小于50岁女性乳腺钼靶筛查结果的特征,尤其是微钙化灶,以提高年轻女性乳腺钼靶筛查的阳性预测值。方法:我们回顾性分析了2013年4月至2015年3月期间在日本静冈县樱之冈医院接受机会性和有组织乳腺癌筛查的连续女性的数据。我们比较了年龄小于40岁、40 - 49岁以及50 - 74岁女性的钼靶检查结果和微钙化灶特征。结果:该研究纳入了3645名女性。其中,415名(11.4%)年龄小于40岁,1219名(33.4%)年龄在40 - 49岁之间,2011名(55.2%)年龄在50 - 74岁之间。年龄小于50岁的女性因微钙化灶被召回的可能性高于年龄在50 - 74岁之间的女性(小于40岁,4.8%;40 - 49岁,4.3%;50 - 74岁,3.3%)。与年龄在50 - 74岁之间的女性相比,年轻女性因小圆形和节段性微钙化灶被召回的可能性更大[小于40岁,比值比(OR):1.799(95%可信区间:0.751 - 2.846);40 - 49岁,OR:1.394(95%可信区间:0.714 - 2.074)],而因小圆形和簇状微钙化灶被召回的可能性较小[小于40岁,OR:0.603(95%可信区间:0.181 - 1.025);40 - 49岁,OR:0.961(95%可信区间:0.496 - 1.428)]。结论:在乳腺钼靶筛查中,年龄小于50岁的女性因微钙化灶,尤其是小圆形和节段性微钙化灶被召回的倾向更高。未来通过反映无乳腺癌年轻女性微钙化灶发现的特征,可能会减少假阳性结果。